Back to Newsroom

Catalyst Pharmaceuticals to Present at 13th Annual BIO Investor Forum

CORAL GABLES, Fla., Oct. 2, 2014 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), (Catalyst Pharmaceuticals) a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that Patrick J. McEnany, Chief Executive Officer, and Steven Miller, Ph.D., Chief Operating Officer and Chief Scientific Officer, will present at the 13th Annual BIO Investor Forum being held at The Palace Hotel in San Francisco, California, October 7-8. The presentation is scheduled for Tuesday, October 7th at 2:00 pm (PDT). The presentation materials will be posted at in the Investors section under Events & Presentations.

Click here to read the full press release